259 related articles for article (PubMed ID: 27736318)
1. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
Aceves M; Bancroft EA; Aceves AR; Hook MA
J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
[TBL] [Abstract][Full Text] [Related]
2. Adverse Effects of Repeated, Intravenous Morphine on Recovery after Spinal Cord Injury in Young, Male Rats Are Blocked by a Kappa Opioid Receptor Antagonist.
Rau J; Hemphill A; Araguz K; Cunningham R; Stefanov A; Weise L; Hook MA
J Neurotrauma; 2022 Dec; 39(23-24):1741-1755. PubMed ID: 35996351
[TBL] [Abstract][Full Text] [Related]
3. Neurobiological Effects of Morphine after Spinal Cord Injury.
Hook MA; Woller SA; Bancroft E; Aceves M; Funk MK; Hartman J; Garraway SM
J Neurotrauma; 2017 Feb; 34(3):632-644. PubMed ID: 27762659
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury.
Aceves M; Mathai BB; Hook MA
Spinal Cord; 2016 Oct; 54(10):767-777. PubMed ID: 26927293
[TBL] [Abstract][Full Text] [Related]
5. An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury.
Hook MA; Washburn SN; Moreno G; Woller SA; Puga D; Lee KH; Grau JW
Brain Behav Immun; 2011 Feb; 25(2):349-59. PubMed ID: 20974246
[TBL] [Abstract][Full Text] [Related]
6. Morphine increases macrophages at the lesion site following spinal cord injury: Protective effects of minocycline.
Aceves M; Terminel MN; Okoreeh A; Aceves AR; Gong YM; Polanco A; Sohrabji F; Hook MA
Brain Behav Immun; 2019 Jul; 79():125-138. PubMed ID: 30684649
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence.
Zan GY; Wang Q; Wang YJ; Liu Y; Hang A; Shu XH; Liu JG
Behav Brain Res; 2015 Sep; 291():334-341. PubMed ID: 26049060
[TBL] [Abstract][Full Text] [Related]
9. The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine.
Timár J; Gyarmati Z; Fürst Z
Brain Res Bull; 2005 Jan; 64(5):417-24. PubMed ID: 15607829
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
11. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
12. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
13. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
[TBL] [Abstract][Full Text] [Related]
14. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
16. The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors.
Smith MA; Greene-Naples JL; Lyle MA; Iordanou JC; Felder JN
J Pharmacol Exp Ther; 2009 Aug; 330(2):468-75. PubMed ID: 19403853
[TBL] [Abstract][Full Text] [Related]
17. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
[TBL] [Abstract][Full Text] [Related]
18. Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine.
Liu NJ; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 Aug; 322(2):654-60. PubMed ID: 17488879
[TBL] [Abstract][Full Text] [Related]
19. The impact of morphine after a spinal cord injury.
Hook MA; Liu GT; Washburn SN; Ferguson AR; Bopp AC; Huie JR; Grau JW
Behav Brain Res; 2007 May; 179(2):281-93. PubMed ID: 17383022
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
